Edwards Lifesciences Corp 4
4 · Edwards Lifesciences Corp · Filed May 12, 2017
Insider Transaction Report
Form 4
Verguet Patrick B
CVP, Europe
Transactions
- Tax Payment
Common Stock
2017-05-10$110.58/sh−494$54,627→ 138,268.15 total - Exercise/Conversion
Common Stock
2017-05-10+9,625→ 138,762.15 total - Exercise/Conversion
Performance Rights
2017-05-10−9,625→ 0 totalExp: 2017-05-31→ Common Stock (9,625 underlying)
Footnotes (2)
- [F1]On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.